Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.
Vaccine
; 35(2): 375-384, 2017 01 05.
Article
in En
| MEDLINE
| ID: mdl-27916408
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Staphylococcus aureus
/
Staphylococcal Vaccines
/
Antigens, Bacterial
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Vaccine
Year:
2017
Document type:
Article